Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.
about
Migration and invasion of drug-resistant lung adenocarcinoma cells are dependent on mitochondrial activityNovel 3-arylethynyl-substituted thieno[3,4-b]pyrazine derivatives as human transglutaminase 2 inhibitors.Ethacrynic Acid Inhibits Sphingosylphosphorylcholine-Induced Keratin 8 Phosphorylation and Reorganization via Transglutaminase-2 Inhibition.Transglutaminase 2 in cancer.Assessment of caroverine as a potential chemotherapeutical agent in HNSCC cell lines.Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.
P2860
Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.
@en
Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.
@nl
type
label
Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.
@en
Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.
@nl
prefLabel
Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.
@en
Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.
@nl
P2093
P2860
P1476
Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor
@en
P2093
Nayeon Kim
Se-Jin Kim
Seon-Hyeong Lee
Soo-Youl Kim
Young-Dae Gong
P2860
P2888
P304
P356
10.1007/S00432-013-1433-1
P50
P577
2013-04-21T00:00:00Z